Cargando…
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia
Background: Corona virus disease (COVID-19) is an infectious respiratory disease that has spread rapidly across the world. Many studies have already evaluated the clinical features of COVID-19, but how it compares with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative community-a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309449/ https://www.ncbi.nlm.nih.gov/pubmed/32612961 http://dx.doi.org/10.3389/fcimb.2020.00322 |
_version_ | 1783549208663425024 |
---|---|
author | Zhou, Yutian Guo, Shujin He, Ye Zuo, Qiunan Liu, Danju Xiao, Meng Fan, Jinxiu Li, Xiaohui |
author_facet | Zhou, Yutian Guo, Shujin He, Ye Zuo, Qiunan Liu, Danju Xiao, Meng Fan, Jinxiu Li, Xiaohui |
author_sort | Zhou, Yutian |
collection | PubMed |
description | Background: Corona virus disease (COVID-19) is an infectious respiratory disease that has spread rapidly across the world. Many studies have already evaluated the clinical features of COVID-19, but how it compares with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative community-acquired pneumonia (SN-CAP) is still unclear. Moreover, COVID-19 mortality is correlated with disease severity, but indicators for severity grading have not been specified. We aimed to analyze the clinical characteristics of COVID-19 in comparison with SN-CAP and find indicators for disease severity in COVID-19. Methods: Patients diagnosed with COVID-19 and SN-CAP were enrolled. Clinical, radiological, and laboratory data were analyzed. Results: The numbers of COVID-19 and SN-CAP patients enrolled were 304 and 138, respectively. The age of the patients was not significantly different between the groups. Compared with SN-CAP, COVID-19 patients had more symptoms of fever and dyspnea; and showed significant difference in blood count results. Computed tomography (CT) imaging of COVID-19 patients showed patchy ground-glass opacities that correlated with disease severity, whereas the CT imaging of SN-CAP patients showed patchy high-density shadows. COVID-19 patients were classified into moderate, severe, and critically severe groups. The severe and critically severe groups had elevated levels of white blood cells (WBC), neutrophils, platelets, C-reaction protein (CRP), lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), troponin-I, creatinine, and blood urea nitrogen (BUN). However, they had decreased levels of lymphocytes, lymphocyte ratio, and albumin. Compared with the younger patients, the older COVID-19 individuals had more chronic diseases and significantly elevated levels of WBC, neutrophil, and CRP levels. Conclusion: SN-CAP showed more inflammatory reaction than COVID-19. Old people with chronic diseases are more susceptible to COVID-19 and have a high likelihood of developing severe and critically severe infection. Levels of WBC, lymphocytes, neutrophils, CRP, NLR, PLR, troponin-I, creatinine, and BUN are important indicators for severity grading in COVID-19. |
format | Online Article Text |
id | pubmed-7309449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73094492020-06-30 COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia Zhou, Yutian Guo, Shujin He, Ye Zuo, Qiunan Liu, Danju Xiao, Meng Fan, Jinxiu Li, Xiaohui Front Cell Infect Microbiol Cellular and Infection Microbiology Background: Corona virus disease (COVID-19) is an infectious respiratory disease that has spread rapidly across the world. Many studies have already evaluated the clinical features of COVID-19, but how it compares with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative community-acquired pneumonia (SN-CAP) is still unclear. Moreover, COVID-19 mortality is correlated with disease severity, but indicators for severity grading have not been specified. We aimed to analyze the clinical characteristics of COVID-19 in comparison with SN-CAP and find indicators for disease severity in COVID-19. Methods: Patients diagnosed with COVID-19 and SN-CAP were enrolled. Clinical, radiological, and laboratory data were analyzed. Results: The numbers of COVID-19 and SN-CAP patients enrolled were 304 and 138, respectively. The age of the patients was not significantly different between the groups. Compared with SN-CAP, COVID-19 patients had more symptoms of fever and dyspnea; and showed significant difference in blood count results. Computed tomography (CT) imaging of COVID-19 patients showed patchy ground-glass opacities that correlated with disease severity, whereas the CT imaging of SN-CAP patients showed patchy high-density shadows. COVID-19 patients were classified into moderate, severe, and critically severe groups. The severe and critically severe groups had elevated levels of white blood cells (WBC), neutrophils, platelets, C-reaction protein (CRP), lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), troponin-I, creatinine, and blood urea nitrogen (BUN). However, they had decreased levels of lymphocytes, lymphocyte ratio, and albumin. Compared with the younger patients, the older COVID-19 individuals had more chronic diseases and significantly elevated levels of WBC, neutrophil, and CRP levels. Conclusion: SN-CAP showed more inflammatory reaction than COVID-19. Old people with chronic diseases are more susceptible to COVID-19 and have a high likelihood of developing severe and critically severe infection. Levels of WBC, lymphocytes, neutrophils, CRP, NLR, PLR, troponin-I, creatinine, and BUN are important indicators for severity grading in COVID-19. Frontiers Media S.A. 2020-06-16 /pmc/articles/PMC7309449/ /pubmed/32612961 http://dx.doi.org/10.3389/fcimb.2020.00322 Text en Copyright © 2020 Zhou, Guo, He, Zuo, Liu, Xiao, Fan and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Zhou, Yutian Guo, Shujin He, Ye Zuo, Qiunan Liu, Danju Xiao, Meng Fan, Jinxiu Li, Xiaohui COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia |
title | COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia |
title_full | COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia |
title_fullStr | COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia |
title_full_unstemmed | COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia |
title_short | COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia |
title_sort | covid-19 is distinct from sars-cov-2-negative community-acquired pneumonia |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309449/ https://www.ncbi.nlm.nih.gov/pubmed/32612961 http://dx.doi.org/10.3389/fcimb.2020.00322 |
work_keys_str_mv | AT zhouyutian covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT guoshujin covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT heye covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT zuoqiunan covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT liudanju covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT xiaomeng covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT fanjinxiu covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia AT lixiaohui covid19isdistinctfromsarscov2negativecommunityacquiredpneumonia |